Page last updated: 2024-08-22

magnesium sulfate and cardiovascular agents

magnesium sulfate has been researched along with cardiovascular agents in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (11.11)	18.7374
1990's	1 (11.11)	18.2507
2000's	5 (55.56)	29.6817
2010's	2 (22.22)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fuchs-Buder, T; Tassonyi, E	1
Torpy, JM	1
IZAR, G	1
Kasegawa, H; Kohno, H; Koyanagi, T; Miyazaki, M	1
Bopp, DJ; Bresnitz, EA; Jensen, BJ; Jernigan, DB; Kacica, MA; Kazakova, S; McDonald, LC; Noble-Wang, JA; Palmieri, MJ; Sickbert-Bennett, EE; Sunenshine, RH; Tan, CG; Tan, ET; Terashita, DM	1
Chan, KH; Ho, CM	1
Kishida, H	1
Colon, M; Gambala, C; Hibbard, JU; Rogers, DT; Wilkins, I	1
Lehmann, DF; Pandita, A	1

Reviews

2 review(s) available for magnesium sulfate and cardiovascular agents

Article	Year
Three-day magnesium administration prevents atrial fibrillation after coronary artery bypass grafting. The Annals of thoracic surgery, 2005, Volume: 79, Issue:1 Topics: Aged; Anesthesia, General; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiovascular Agents; Coronary Artery Bypass; Drug Administration Schedule; Drug Evaluation; Female; Humans; Incidence; Infusions, Intravenous; Magnesium Sulfate; Male; Middle Aged; Monitoring, Physiologic; Postoperative Complications; Prospective Studies; Research Design; Retrospective Studies; Stroke Volume; Treatment Outcome	2005
[Drug-induced long QT syndrome]. Nihon rinsho. Japanese journal of clinical medicine, 2007, Oct-28, Volume: 65 Suppl 8 Topics: Anti-Allergic Agents; Anti-Bacterial Agents; Antineoplastic Agents; Cardiovascular Agents; Central Nervous System Agents; Drug Interactions; Drugs, Chinese Herbal; Electric Countershock; Humans; Long QT Syndrome; Magnesium Sulfate; Time Factors	2007

Article

Year

Three-day magnesium administration prevents atrial fibrillation after coronary artery bypass grafting.

The Annals of thoracic surgery, 2005, Volume: 79, Issue:1

Topics: Aged; Anesthesia, General; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiovascular Agents; Coronary Artery Bypass; Drug Administration Schedule; Drug Evaluation; Female; Humans; Incidence; Infusions, Intravenous; Magnesium Sulfate; Male; Middle Aged; Monitoring, Physiologic; Postoperative Complications; Prospective Studies; Research Design; Retrospective Studies; Stroke Volume; Treatment Outcome

2005

[Drug-induced long QT syndrome].

Nihon rinsho. Japanese journal of clinical medicine, 2007, Oct-28, Volume: 65 Suppl 8

Topics: Anti-Allergic Agents; Anti-Bacterial Agents; Antineoplastic Agents; Cardiovascular Agents; Central Nervous System Agents; Drug Interactions; Drugs, Chinese Herbal; Electric Countershock; Humans; Long QT Syndrome; Magnesium Sulfate; Time Factors

2007

Trials

1 trial(s) available for magnesium sulfate and cardiovascular agents

Article	Year
Magnesium sulphate enhances residual neuromuscular block induced by vecuronium. British journal of anaesthesia, 1996, Volume: 76, Issue:4 Topics: Anesthesia, General; Cardiovascular Agents; Drug Interactions; Humans; Magnesium Sulfate; Nerve Block; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Postoperative Care; Postoperative Period; Vecuronium Bromide	1996

Other Studies

6 other study(ies) available for magnesium sulfate and cardiovascular agents

Article	Year
Clinical evidence for critical cardiac care. JAMA, 2002, Apr-03, Volume: 287, Issue:13 Topics: Angina, Unstable; Cardiovascular Agents; Clinical Trials as Topic; Critical Care; Defibrillators, Implantable; Evidence-Based Medicine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lidocaine; Magnesium Sulfate; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex	2002
[ON THE THERAPY OF TETANUS]. Minerva medica, 1964, Aug-18, Volume: 55 Topics: Barbiturates; Cardiovascular Agents; Chloroform; Humans; Immunization, Passive; Magnesium Sulfate; Muscle Relaxants, Central; Tetanus; Tetanus Antitoxin; Tetanus Toxoid	1964
A multistate outbreak of Serratia marcescens bloodstream infection associated with contaminated intravenous magnesium sulfate from a compounding pharmacy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Sep-01, Volume: 45, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; Cardiac Surgical Procedures; Cardiovascular Agents; Centers for Disease Control and Prevention, U.S.; Cross Infection; Disease Outbreaks; Drug Compounding; Drug Contamination; Female; Humans; Los Angeles; Magnesium Sulfate; Male; Middle Aged; New Jersey; Risk Factors; Serratia Infections; Serratia marcescens; United States	2007
Posterior reversible encephalopathy syndrome with vasospasm in a postpartum woman after postdural puncture headache following spinal anesthesia. Anesthesia and analgesia, 2007, Volume: 105, Issue:3 Topics: Adult; Anesthesia, Spinal; Brain Edema; Brain Ischemia; Cardiovascular Agents; Cesarean Section; Diffusion Magnetic Resonance Imaging; Female; Humans; Magnesium Sulfate; Magnetic Resonance Angiography; Post-Dural Puncture Headache; Postpartum Period; Pregnancy; Syndrome; Treatment Outcome; Vasospasm, Intracranial	2007
Effects of magnesium on central arterial compliance in preeclampsia. American journal of obstetrics and gynecology, 2010, Volume: 202, Issue:5 Topics: Adult; Arteries; Blood Pressure; Cardiovascular Agents; Compliance; Elasticity; Female; Humans; Magnesium Sulfate; Manometry; Pre-Eclampsia; Pregnancy; Radial Artery; Regional Blood Flow; Vasoconstriction; Young Adult	2010
Magnesium Sulfate Treatment Correlates With Improved Neurological Function in Posterior Reversible Encephalopathy Syndrome (PRES): Report of a Case. The neurologist, 2018, Volume: 23, Issue:2 Topics: Adult; Cardiovascular Agents; Humans; Magnesium Sulfate; Male; Posterior Leukoencephalopathy Syndrome; Treatment Outcome	2018